PAUL SCHULER

SHREVEPORT, LA NPI 1881662682

This page merges CMS profile IDs: 1306761, 8801169 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$5,064.81

  • Category: General Payments
  • Program years: PY2018–2020
  • Record count: 380
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $372.41 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $372.4119

By paying entity

Latest program year (PY2020) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $2,173.47182
2019 $2,518.93179
2020 $372.4119

Records — PY2020 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
719347673 Actelion Pharmaceuticals US, Inc. $22.47 02/04/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719347675 Actelion Pharmaceuticals US, Inc. $23.70 01/02/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
720509737 Boehringer Ingelheim Pharmaceuticals, Inc. $20.93 02/05/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
720509743 Boehringer Ingelheim Pharmaceuticals, Inc. $15.25 02/03/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
720509747 Boehringer Ingelheim Pharmaceuticals, Inc. $18.40 01/13/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
720509751 Boehringer Ingelheim Pharmaceuticals, Inc. $14.87 01/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
726121267 Novartis Pharmaceuticals Corporation $22.86 01/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
726121271 Novartis Pharmaceuticals Corporation $18.79 02/25/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
726900909 Paratek Pharmaceuticals, Inc. $22.89 02/11/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738499589 GlaxoSmithKline, LLC. $15.08 02/26/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738584921 GlaxoSmithKline, LLC. $19.87 02/19/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738613297 GlaxoSmithKline, LLC. $12.58 02/28/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738711257 GlaxoSmithKline, LLC. $15.79 01/29/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
743079249 Genentech USA, Inc. $16.85 02/24/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747636445 Merck Sharp & Dohme Corporation $11.33 01/16/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748290983 La Jolla Pharmaceutical Company $19.93 02/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
750489967 Grifols USA, LLC $18.79 01/21/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
751378739 Philips Electronics North America Corporation $47.84 02/18/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
752460813 United Therapeutics Corporation $14.19 01/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
  • Merged CMS profile IDs: 1306761, 8801169

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.